Literature DB >> 33433387

Excipients as Potential Agents of Anaphylaxis in Vaccines: Analyzing the Formulations of Currently Authorized COVID-19 Vaccines.

M L Caballero1, S Quirce1.   

Abstract

Entities:  

Keywords:  Allergy; Anaphylaxis; COVID-19; Coronavirus; Excipient; Immediate drug hypersensitivity reaction; Pharmaceutical excipients; Vaccine

Year:  2020        PMID： 33433387     DOI： 10.18176/jiaci.0667

Source DB:  PubMed          Journal:  J Investig Allergol Clin Immunol        ISSN： 1018-9068            Impact factor:   4.333


× No keyword cloud information.
  10 in total

Review 1.  To PEGylate or not to PEGylate: Immunological properties of nanomedicine's most popular component, polyethylene glycol and its alternatives.

Authors:  Da Shi; Damian Beasock; Adam Fessler; Janos Szebeni; Julia Y Ljubimova; Kirill A Afonin; Marina A Dobrovolskaia
Journal:  Adv Drug Deliv Rev       Date:  2021-12-10       Impact factor: 15.470

Review 2.  Emerging biomaterial-based strategies for personalized therapeutic in situ cancer vaccines.

Authors:  Dixita Ishani Viswanath; Hsuan-Chen Liu; David P Huston; Corrine Ying Xuan Chua; Alessandro Grattoni
Journal:  Biomaterials       Date:  2021-11-30       Impact factor: 12.479

3.  Skin tests in urticaria/angioedema and flushing to Pfizer-BioNTech SARS-CoV-2 vaccine: Limits of intradermal testing.

Authors:  Leonardo Bianchi; Filippo Biondi; Katharina Hansel; Nicola Murgia; Marta Tramontana; Luca Stingeni
Journal:  Allergy       Date:  2021-04-22       Impact factor: 14.710

4.  Local skin reaction to the AZD1222 vaccine in a patient who survived COVID-19.

Authors:  Antonella Tammaro; Ganiyat Adenike Ralitsa Adebanjo; Francesca Magri; Francesca Romana Parisella; Camilla Chello; Gabriella De Marco
Journal:  J Cosmet Dermatol       Date:  2021-05-22       Impact factor: 2.696

Review 5.  Cutaneous and hypersensitivity reactions associated with COVID-19 vaccination-a narrative review.

Authors:  Uwe Wollina; Anca Chiriac; Hristina Kocic; André Koch; Piotr Brzezinski
Journal:  Wien Med Wochenschr       Date:  2021-08-23

6.  Potential Anionic Substances Binding to Platelet Factor 4 in Vaccine-Induced Thrombotic Thrombocytopenia of ChAdOx1-S Vaccine for SARS-CoV-2.

Authors:  Xiaocong Pang; Haitao Liu; Xu He; Tianrong Ji; Yizhun Zhu; Yimin Cui
Journal:  Front Immunol       Date:  2022-01-12       Impact factor: 7.561

Review 7.  Updated consensus statements on COVID-19 Vaccine Allergy Safety in Hong Kong.

Authors:  Valerie Chiang; Agnes S Y Leung; Elaine Y L Au; Marco H K Ho; Tak Hong Lee; Adrian Y Y Wu; Gary W K Wong; Philip H Li
Journal:  Asia Pac Allergy       Date:  2022-01-24

Review 8.  What have we learned about the allergenicity and adverse reactions associated with the severe acute respiratory syndrome coronavirus 2 vaccines: One year later.

Authors:  Ana M Copaescu; Jaime S Rosa Duque; Elizabeth Jane Phillips
Journal:  Ann Allergy Asthma Immunol       Date:  2022-04-04       Impact factor: 6.248

Review 9.  Nanoparticles in clinical trials of COVID-19: An update.

Authors:  Abdur Rauf; Tareq Abu-Izneid; Anees Ahmed Khalil; Nabia Hafeez; Ahmed Olatunde; Mominur Rahman; Prabhakar Semwal; Yahya Saleh Al-Awthan; Omar Salem Bahattab; Ishaq N Khan; Muhammad Arslan Khan; Rohit Sharma
Journal:  Int J Surg       Date:  2022-08-08       Impact factor: 13.400

Review 10.  Towards novel nano-based vaccine platforms for SARS-CoV-2 and its variants of concern: Advances, challenges and limitations.

Authors:  Sally A Helmy; Rasha M El-Morsi; Soha A M Helmy; Soha M El-Masry
Journal:  J Drug Deliv Sci Technol       Date:  2022-09-08       Impact factor: 5.062
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.